Success Rate of Furazolidone Based Triple Therapy for Eradication of Helicobacter Pylori in Children
|
|
- Godfrey Hardy
- 5 years ago
- Views:
Transcription
1 Original Article Iran J Pediatr Sep 2008; Vol 19 (No 3), Pp: Success Rate of Furazolidone Based Triple Therapy for Eradication of Helicobacter Pylori in Children Mehri Najafi, MD* 1 ; Ahmad Khodadad, MD 1 ; Gholamhossein Fallahi, MD; Fatemeh Farahmand 1, MD; Farzaneh Motamed, MD 1 ; Mohammad Sobhani 1, MD 1. Department of Pediatrics, Tehran University of Medical Sciences, Tehran, IR Iran Received: Oct 07, 2008; Final Revision: Jan 08, 2009; Accepted: Mar 07, 2009 Abstract Objective: Helicobacter pylori (H. Pylori) is now recognized as a major etiological factor in the pathogenesis of gastritis and peptic ulcer disease. There is concrete evidence that eradication of the bacterium reverses histological gastritis, and results in significant reduction of duodenal and gastric ulcer recurrence. Poor compliance and antibiotic resistance are the main causes for failure of anti H. pylori therapy. In this study we determined efficacy of omeprazole based triple therapy with b.i.d. dosing of furazolidone, amoxicillin for 2 weeks and omeprazole in Iranian children. Methods: This prospective study included 37 children, in whom H. Pylori infection was diagnosed endoscopically. H.Pylori positive children were treated with a two weeks course of furazoidone (6 mg/kg/day) and amoxicillin (50 mg/kg/day) plus omeprazole (1 2 mg/kg/day). Eradication was assessed by 13 C UBT. Findings: Mean age of patients was 10.2 yr (5 15 yr), 25 (67.5%) patients were boys. H. Pylori was eradicated in 34 children (per patient 91.9%, per protocol 86%). Side effects occurred in 3 (8.1%) patients, but these were mild and it was not necessary to discontinue treatment. Three children (8.1%) remained H. pylori positive. Conclusion: Our study showed that the association of furazolidone plus amoxicillin with a proton pump inhibitor could be a valuable alternative for eradication of H. Pylori infection in children. It is an effective, affordable treatment that allows good compliance and produces low adverse effect rates. Iranian Journal of Pediatrics, Volume 19 (Number 3), September 2009, Pages: Key Words: Helicobacter pylori; Furazolidone; Omeprazole triple therapy; Children * Corresponding Author; Address: Gastroenterology Division, Pediatrics Excellence Center, Children's Medical Center, Dr Gharib St, Keshavarz Blvd, Tehran, IR Iran najafisa@sina.tums.ac.ir 2009 by Pediatrics Center of Excellence, Children s Medical Center, Tehran University of Medical Sciences, All rights reserved.
2
3 Iran J Pediatr; Vol 19 (No 3); Sep Introduction Helicobacter pylorus is now recognized as a major etiological factor in the pathogenesis of gastritis and peptic ulcer disease [1]. There is concrete evidence that eradication of the bacterium reverses histological gastritis, and results in significant reduction of duodenal and gastric ulcer recurrence [1]. A recent meta analysis concluded that recurrent infection is rare when eradication rates exceed 90% [2]. Eradication regimens for H. pylori must be effective, safe, with minimal induction of resistance. In Asia, H. pylori eradication is difficult and generally two weeks of treatment is necessary [3,4]. Metronidazole resistance is a common problem and clarithromycin is expensive [5,6] but H. pylori is sensitive to Furazolidone and reports of resistance have been scarce so far [6 8]. Furazolidone was effective against H. pylori in Iranian patients and was a good substitute for clarithromycin or metronidazole [9,10,11]. In addition to its efficacy, Furazolidone is a relatively inexpensive and easily affordable medication. In many of reports furazolidone consumption for two weeks in adults was associated with adverse reactions such as anorexia, dizziness, urticarial rash, flu like symptoms, and fever in 5 15% of cases, therefore, limiting its prescription [5,9]. The early childhood years are important with regard to exposure to H. pylori infection, with higher rates of acquisition than during the adult years [12,13]. When selecting a therapy to eradicate H. pylori, duration of treatment and adverse effects should be considered [1]. Until recently, the recommended duration of therapy for H. pylori eradication was one to two weeks. In this study we determined efficacy of triple therapy and two antibiotics (furazolidone, and amoxicillin) for 2 weeks. study. Patients who had undergone previous H. Pylori eradication therapy prior to the study or had a previous history of severe renal and hepatic disease were excluded from the study. Upper gastrointestinal endoscopy was carried out after midazolam sedation (0.1 mg per kg). Gastric antral biopsy specimens were taken for histology examination, Giemsa staining and urease testing. The presence of H. Pylori in histology was accepted as diagnostic for infection. H. Pylori positive children were treated with a two week course of amoxicillin (50 mg/kg/day b.i.d. as syrup or capsule) and furazolidone (6 mg/kg/day b.i.d. as syrup or tablet) plus four weeks omeprazole (1 2 mg/kg/day), and reinvestigated eight to ten weeks after accomplished treatment by urea breath test ( 13 C UBT). This test was performed after a fasting period of 6 hours or longer. The patients swallowed capsules containing urea labeled 13 C (non radioactive) and 13 C in the expired air was measured 20 minutes later, using an infrared spectrophotometer (IRIS, Dr. Wagner, Bremen, Germany). The difference between the values obtained at 20 minutes and at baseline was expressed as delta over baseline (DOB %). The cut off value for negative UBT was less than 2.5 and for positive UBT more than 4.0 δ unit (delta over base). Children, in whom H. Pylori persisted, were treated successfully with quadruple regimen (omeprazole, amoxicillin, bismuth subcitrate and clarithromycin). The Ethics Committee of Tehran University of Medical Sciences approved the protocol. Statistical analysis: Chi square test or Fisher's exact test was used for qualitative variables and the Student t test for quantitative variables. SPSS software for Windows version 15 was then used for processing of data. A P value of less than 0.05 was considered significant. Subjects and Methods Children with chronic abdominal pain, hematemesis, and melena between 2.5 and 16 years of age were prospectively recruited during 2006 and Children with H. Pylori infection confirmed by endoscopy and pathology entered the Findings Thirty seven children fulfilled inclusion criteria. Their mean age was10.2 years, range 5 to 17 (10.9± 2.5) years and 25 (67.5%) of
4 246 Furazolidone for Eradication of H. Pylori; M Najafi, et al them were boys. Characteristics of patients and endoscopic findings are shown in tables 1 and 2. Table 1: Characteristics of study patients Characteristics No Median age (range) 10.2 (5 17) Sex (male) 25 (67.5%) Abdominal pain (%) 28 (75.7%) Hematemesis/melena (%) 8 (21.6%) Vomiting (%) 8 (21.6%) Table 2: Endoscopic findings in 37 patients with H. Pylori Endoscopic findings Normal Antral nodularity Gastric erythema Duodenal ulcer Gastric ulcer All 37 children completed treatment protocol combined of amoxicillin and furazulidone and omeprazole. Side effects occurred in three (8.1 %) children: (abdominal pain in two, vomiting, and headache each affected one child), but these were mild and it was not necessary to discontinue treatment. Overall, the eradication was cleared in 34 of 37 children, giving an eradication rate of 91.9% (95% CI, 83% 98%) in ITT analysis. Three children (8.1%) remained H. pylori positive. All of these persistently H. pylori positive children had cleared from infection by a quadruple therapy (omeprazole, bismuth subcitrate, amoxicillin, clarithro mycin). Discussion No (%) 7 (18.9) 22 (73.3) 16 (53.3) 7 (23.3) 0 Treatment of H. Pylori infection is definitely indicated in children with proven H. Pylori gastritis, but also no ulcer need be treated is still debated. Treatment induces the eventual healing of inflammation and ulceration and significant reduction in the likelihood of developing gastric carcinoma [14]. However, after H. Pylori gastritis is diagnosed, the current approach is to treat the patient [15]. Triple treatment including a proton pump inhibitor (PPI) and clarithromycin, combined with either amoxicillin or metronidazole has been recommended to treat children with H. pylori infection [16]. In children all regimens should continue for 7 14 days [14]. However antibiotic resistance is increasing, so new therapeutic regimens are needed [17,18]. In this study we show that administering furazolidone for 2 weeks b.i.d. plus omeprazole and amoxicillin in a triple anti H. pylori treatment regimen has a high eradication rate (per patient 91.9%, per protocol 86%). One of the great impediments regarding the use of furazolidone is its association with some side effects, reported mainly from adults and studies carried out in Europe [9,19]. In our study however, no patient had to interrupt the treatment due to side effects. The results of H. Pylori treatment in children are different from that in adults. So some authors concluded that treatment recommended for adults may be not suitable for children [20]. Bahremand et al, compared a triple therapy (omeprazole, amoxicillin, and clarithromycin) to a quadruple therapy (omeprazole, amoxicilline, metronidazole and bismuth subcitrate for 10 days), in Iranian children with H. pylori infection. The eradication rates were higher in triple versus bismuth quadruple therapy (92% vs. 84%) [21]. In the study of Arenz et al [22] one week esomeprazole based triple therapy (amoxicillin, clarithromycin) was very effective in eradication of H. Pylori in children (92 93%). The rate of resistance was 9% for clarithromycin and 16% for metronidazole. Triple therapy is more effective than dual therapy [23]. In Iranian children the rate of resistance to metronidazole was very high (72 79%), and
5 Iran J Pediatr; Vol 19 (No 3); Sep susce ptibility to amoxicillin was 58% and 75% for clarithromycin [24]. In another study from Iran [25] the rate of resistance to metronidazole was (54.2%), and there was no resistance to furazolidone. Kawakami et al treated 38 children with omeprazole, clarithromycin and furazolidone for 7 days [26]. The rate of success was 84.8% per patient and 73.7% per protocol. So treatment of H. Pylori in children needs more designed randomized placebocontrolled trials, especially in developing countries [27]. The high rate of resistance to antibiotics in these countries and also low compliance for drug intake are the main reasons for treatment failure [28]. Our limitations: Peptic disease in children is much less than in adults, and also some of the parents are not consent to endoscopy. So gathering sufficient sample is difficult. Conclusion Triple omerazole based therapy (OAF) could be a valuable alternative to first line eradication therapy of H. pylori in children. It is an effective, affordable treatment that allows good compliance and produce low adverse effect rates, but further multicenter trials are needed to establish its role in the H. Pylori infection. Acknowledgment This study was approved by research committee of Tehran University of Medical Sciences. We thank greatly Mrs. Sadeghie responsible in Radio Isotope Ward of Dr Shareiatee Hospital, and also Mrs. M. Madadie and S. Tafreshie proficient nurses of Children's Medical Center Endoscopy Unit for their unreserved cooperation. References 1. Khor CJ, Fock KM, Ng TM, et al. Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban East Asian population. Singapore Med J. 2000; 41(8): Xia HX, Talley NJ, Keane CT, et al. Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci. 1997;42(9): Saberi Firoozi M, Massarrat S, Zare S, et al. Effect of triple therapy or amoxicillin plus omeprazole or amoxicillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over 1 year follow up period: a randomized controlled study. Am J Gastroenterol. 1995;90(9): Kashifard M, Malekzadeh R, Siavoshi F, et al. Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy compromising omeprazole and amoxicillin. Eur J Gastroenterol Hepatol. 1998;10(10): Roghani HS, Massarrat S, Pahlewanzadeh MR, et al. Effect of two doses of metronidazole and tetracycline in bismuth triple therapy on eradication of H. pylori and its resistant strains. Eur J Gastroenterol Hepatol. 1999;11(7): Siavoshi F, Safari F, Doratotaj D, et al. Antimicrobial resistance of Helicobacter Pylori isolates from Iranian adults and children. Arch Iran Med. 2006;9(4): Kwon DH, Lee M, Kim JJ, et al. Furazolidone and nitrofurantoin resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob Agents Chemother. 2001;45(1): Howden A, Boswell P, Tovey F. In vitro sensitivity of Campylobacter pyloridis to furazolidone. Lancet. 1986;2(8514): Fakheri H, Malekzadeh R, Merat S, et al. Clarithromycin vs. furazolidone in
6 248 Furazolidone for Eradication of H. Pylori; M Najafi, et al quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther. 2001;15(3): Fakheri H, Merat S, Hosseini V, et al. Low dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2004;19(1): Roghani HS, Massarrat S, Shirekhoda M, et al. Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori. J Gastroenterol Hepatol. 2003;18(7): Mitchell HM, Li YY, Hu PJ, et al. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Inf Dis. 1992;166(1): Klein PD, Gilman RH, Leon Barua R, et al. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol. 1994; 89(12): Ables AZ, Simon I, Melton ER. Update on Helicobacter pylori Treatment. Am Fam Phys. 2007;75(3): Chelimsky G, Blanchard SS, Czinn SJ. Helicobacter pylori in children and adolescents. Adolesc Med Clin. 2004; 15(1)53 66.: 16. Bourke B, Ceponis P, Chiba N, et al. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents an evidence based evaluation. Can J Gastroenterol. 2005;19(7): Elitsur Y, Lawrence Z, Russmann H, et al. Primary clarithromycin resistance to Helicobacter pylori and therapy failure in children: the experience in West Virginia. J Pediatr Gastroenterol Nutr. 2006:42(3): Crone J, Granditsch G, Huber WD, et al. Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, J Pediatr Gastroenterol Nutr. 2003;36(3): Altamirano A, Bondani A. Adverse reactions to furazolidone and other drugs a comparative review. Scand J Gastroenterol. 1989;169(1): Oderda G, Shcherbakov P, Bontems P, et al. Results from the pediatric European register for treatment of Helicobacter pylori. Helicobacter. 2007;12(2): Bahremand S, Nematollahi LR, Fourutan H, et al. Evaluation of triple therapy and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial. Europ J Gastroenterol Hepatol. 2006;18(5): Arenz T, Antos D, Russmann H, et al. Esomeprazole based 1 week triple therapy directed by susceptibility testing for eradication of Helicobacter Pylori infection in children. J Pediatr Gastroenterol Nutr. 2006;43(2): Cadranel S, Bontemps P, van Biervliet S, et al. Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy. Acta Paediatr. 2007;96(1): Falsafi T, Mobasheri F, Nariman F, et al. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the Pediatric Medical Center of Tehran/Iran. J Clin Microbiol. 2004;42(1): Fallahi Gh, Maleknejad S. Helicobacter pylori culture and antimicrobial resistance in Iran. Indian J Pediatr. 2007;74(2): Kawakami AP, Machado RS, Ogata SK et al. Furazolidone based triple therapy for H. Pylori gastritis in children. World J Gastroenterol. 2006;12(34): Khurana R, Fischbach L, Chiba N, et al. Meta analysis: Helicobacter pylori eradication treatment efficacy in children. Aliment Pharmacol Ther. 2007;25(5): Horvitz G, Gold BD. Gastroduodenal diseases of childhood. Curr Opin Gastroenterol. 2006;22(6):
Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.
An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology
More informationEfficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children
pissn: 2234-8646 eissn: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.237 Pediatric Gastroenterology, Hepatology & Nutrition 2012 December 15(4):237-242 Original Article PGHN Efficacy of Proton Pump
More informationCOMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
Phil J Gastroenterol 2006; 2: 25-29 COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Marianne P Collado, Ma Fatima P Calida, Peter P Sy,
More informationComparing furazolidone and tetracycline in quadruple therapy for eradication helicobacter pylori in dyspepsia patients
Gastroenterology and Hepatology from bed to bench. 2008;1(1):39-43 2008 RCGLD, Research Center for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Comparing furazolidone and tetracycline in quadruple
More informationFurazolidone-Based, Metronidazole-Based, or a Combination Regimen for Eradication of Helicobacter pylori in Peptic Ulcer Disease
Arch Iranian Med 2007; 10 (2): 161 167 Original Article Furazolidone-Based, Metronidazole-Based, or a Combination Regimen for Eradication of Helicobacter pylori in Peptic Ulcer Disease Morteza Khatibian
More informationA Multi-Criteria Decision Making Model for Treatment of Helicobacter pylori Infection in Children
HK J Paediatr (new series) 2012;17:237-242 A Multi-Criteria Decision Making Model for Treatment of Helicobacter pylori Infection in Children A ERJAEE, M BAGHERPOUR, S RAZEGHI, SM DEHGHANI, MH IMANIEH,
More informationShort-Duration Furazolidone Therapy in Combination with Amoxicillin, Bismuth Subcitrate, and Omeprazole for Eradication of Helicobacter pylori
Original Article Short-Duration Furazolidone Therapy in Combination with Amoxicillin, Bismuth Subcitrate, and Omeprazole for Eradication of Helicobacter pylori Salman R. Hasan, Vahabzadeh Vahid 2, Pahlvanzadah
More informationLow Dose Furazolidone for Eradication of H- pylori Instead of Clarithromycin: A Clinical Trial
Global Journal of Health Science; Vol. 7, No. 1; 2015 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Low Dose Furazolidone for Eradication of H- pylori Instead of
More informationWhat is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?
What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori? Sequential Therapy Versus Standard Triple- Drug Therapy for Helicobacter pylori
More informationHelicobacter pylori infection: several studies on epidemiology, eradication and gastric epithelial cell turnover Liu, W.
UvA-DARE (Digital Academic Repository) Helicobacter pylori infection: several studies on epidemiology, eradication and gastric epithelial cell turnover Liu, W. Link to publication Citation for published
More informationEfficacy of standard triple therapy versus bismuth-based quadruple therapy for eradication of Helicobacter Pylori infection
Efficacy of standard triple therapy versus bismuth-based quadruple therapy for eradication of Helicobacter Pylori infection Ramin Talaie Modarress Hospital, Shahid Beheshti University of Medical Sciences,
More informationEDUCATION PRACTICE. Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? Clinical Scenario.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:1086 1090 EDUCATION PRACTICE Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? RICHARD J. SAAD* and WILLIAM D.
More informationHelicobacter pylori: Diagnosis, treatment and risks of untreated infection
Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Klaus Mönkemüller Department of Gastroenterology, Hepatology und Infectius Diseases Otto-von-Guericke University, Magdeburg bb
More informationTreating H. pylori in 2016
Treating H. pylori in 2016 William D. Chey, MD, FACG Professor of Medicine University of Michigan The Case: A 38 yo Russian man presents with recurrent epigastric pain which occurs after meals and sometimes
More informationHelicobacter pylori infection: several studies on epidemiology, eradication and gastric epithelial cell turnover Liu, W.
UvA-DARE (Digital Academic Repository) Helicobacter pylori infection: several studies on epidemiology, eradication and gastric epithelial cell turnover Liu, W. Link to publication Citation for published
More informationUrea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013
MP 2.04.04 Urea Breath Test for Diagnosis of Helicobactor pylori Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index
More informationGilles Jequier. Commercial Director Organobalance, a Novozymes Company
"Latest clinical Evidences showing that a proprietary Lactobacillus reuteri Strain can reduce the Symptoms associated with a Helicobacter pylori Infection" Gilles Jequier Commercial Director Organobalance,
More information헬리코박터파일로리감염에서고용량및다빈도덱스란소프라졸과아모시실린이중치료 : 단일군전향연구
Korean J Gastroenterol Vol. 70 No. 4, 176-180 https://doi.org/10.4166/kjg.2017.70.4.176 pissn 1598-9992 eissn 2233-6869 ORIGINAL ARTICLE 헬리코박터파일로리감염에서고용량및다빈도덱스란소프라졸과아모시실린이중치료 : 단일군전향연구 박혜윤, 강은정, 김동근, 김기주,
More informationThree-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study
Aliment Pharmacol Ther 2001; 15: 843±849. Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study B. C. Y. WONG*, W. H. WANG*, W.M.WONG*,G.K.K.LAU*,F.M.Y.FUNG*,N.N.S.KUNGà,
More informationHelicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationOriginal article J Bas Res Med Sci 2015; 2(4):45-50.
Comparison between the effectiveness of Furazolidone and Clarithromycin on eradication of helicobacter pylori among patients with peptic ulcer Asghar Rahmani 1, Ali Jafari Haidarloo 2, Hoda Mabrokzadeh
More informationACG Clinical Guideline: Treatment of Helicobacter pylori Infection
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection William D. Chey, MD, FACG 1, Grigorios I. Leontiadis, MD, PhD 2, Colin W. Howden, MD, FACG 3 and Steven F. Moss, MD, FACG 4 1 Division
More informationOriginal Policy Date
MP 2.04.38 Genetic Testing for Helicobacter pylori Treatment Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return
More informationProbiotics for the Treatment of Pediatric Helicobacter Pylori Infection: A Randomized Double Blind Clinical Trial
Original Article Iran J Pediatr Feb 2013; Vol 23 (No 1), Pp: 79-84 Probiotics for the Treatment of Pediatric Helicobacter Pylori Infection: A Randomized Double Blind Clinical Trial Khodadad, Ahmad 1,2,3,
More informationManagement of dyspepsia and of Helicobacter pylori infection
Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia
More informationPrevpac Pylera Omeclamox-Pak
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.21 Subject: -Pak Page: 1 of 5 Last Review Date: September 20, 2018 -Pak Description (lansoprazole,
More informationCHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)?
CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS 1. Which of the following is not a common cause of peptic ulcer disease (PUD)? A. Chronic alcohol ingestion B. Nonsteroidal antiinflammatory
More informationKK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011
KK College of Nursing Peptic Ulcer Badil Dass, Lecturer 25 th July, 2011 Objectives: By the end of this lecture, the students t will be able to: Define peptic pp ulcer Describe the etiology and pathology
More informationHelicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens
Helicobacter ISSN 1523-5378 Filipec Blackwell Oxford, HEL 1083-4389 1523-5378 Journal XXX Original H. 2008 pylori Kanizaj compilation The UK Eradication Publishing Article Authors et al. Ltd 2008 Therapy
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA o Patients of any age with ALARM signs should be referred through the 2-week referral system o Routine endoscopic investigation
More informationHealth technology The use of four different combined treatments for Helicobacter pylori (H. pylori) infection. These were:
Tratamiento de la infeccion por Helicobacter pylori en pacientes con ulcera duodenal: estudio de costo-beneficio [Treatment of Helicobacter pylori infection in patients with duodenal ulcer: a cost-benefit
More informationMEDICAL POLICY EFFECTIVE DATE: 05/19/11 REVISED DATE: 05/24/12, 05/23/13 ARCHIVED DATE: 05/22/14 EDITED DATE: 05/28/15, 05/25/16, 05/18/17, 05/17/18
MEDICAL POLICY SUBJECT: NON-INVASIVE HELICOBACTER PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationTreatment of Helicobacter pylori Infection
Treatment of Helicobacter pylori Infection Epidemiology of H. pylori infection (North America) Which are the high risk groups? Epidemiology of H. pylori infection (North America) Which are the high risk
More informationProton Pump Inhibitors Drug Class Prior Authorization Protocol
Proton Pump Inhibitors Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: November 15, 2017 Effective Date: January 1, 2018 This policy has been developed through review
More informationPerspectives from Viet Nam
International Symposium I (Management of antibiotics-resistant Helicobacter pylori infection) Perspectives from Viet Nam Vu Van Khien 1,HoDangQuyDung 2, Tran Thanh Binh 2 1 Department of GI Endoscopy,
More informationDisclosures. Co-founder and Chief Science Officer, TechLab
H. pylori testing Disclosures Co-founder and Chief Science Officer, TechLab Learning Objectives Evaluate the appropriate testing methodology by balancing performance, economics, and workflow. Discuss the
More informationPEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School
PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School No disclosures Disclosures Overview Causes of peptic ulcer disease
More informationHigh use of maintenance therapy after triple therapy regimes in Ireland
High use of maintenance therapy after triple therapy regimes in Ireland K Bennett, H O Connor, M Barry, C O Morain, J Feely Department of Pharmacology & Therapeutics Department of Gastroenterology Trinity
More informationinstrument. When 13C-UBT positive value is greater than or equal to / - 0.4, the the subject can be 1. Data and methods details are as follows:
Application of 13 C-urea breath test in screening helicobacter pylori infection during health examination in Chengdu, Sichuan YANG Yan-hua. LIU Yu-ping. CHENG You-fu, SHUAI Ping. LU Qiao. ZHENG Xiao-xia,
More informationComparative study of invasive methods for diagnosis of Helicobacter pylori in humans
ISSN: 2319-7706 Volume 2 Number 7 (2013) pp. 63-68 http://www.ijcmas.com Original Research Article Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans V.Subbukesavaraja
More informationLow-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients
Blackwell Science, LtdOxford, UKJGHJournal of Gastroenterology and Hepatology0815-93192005 Blackwell Publishing Asia Pty Ltd206935940Original ArticleLow-dose rabeprazole-based triple therapywm Wong et
More informationEradication Rate of Helicobacter pylori using a Two-week Quadruple Therapy: A Report from Southern Iran
1 Original Article Eradication Rate of Helicobacter pylori using a Two-week Quadruple Therapy: A Report from Southern Iran Mohsen Masoodi 1,2*, Mohammad Panahian 1, Amirmansoor Rezadoost 1, Amin Heidari
More information헬리코박터제균요법에있어서 CYP2C19 유전형이판토프라졸과라베프라졸포함치료법에미치는영향. Introduction 울산대학교의과대학서울아산병원소화기내과
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Vol. 8, No. 1, 15-19, July 2008 Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: Comparison between Pantoprazole
More informationA Comparison between Moderate- and High-dose Furazolidone in Triple Regimens for Helicobacterpylori Eradication in Iran BACKGROUND
Original Article 195 A Comparison between Moderate- and High-dose Furazolidone in Triple Regimens for Helicobacterpylori Eradication in Iran Vahid Hosseini 1, Marjan Mokhtare 1, Mohsen Gholami 1, Tarang
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: helicobacter_pylori_testing 01/01/2019 N/A 01/01/2020 01/01/2019 Policy Effective April 1, 2019 Description
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adherence, to bismuth quadruple therapy, 543 546 Adjuvant therapy, probiotics as, 567 569 Age factors, in gastric cancer, 611 612, 616 AID protein,
More informationEMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated
EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both
More informationThe role of antisecretory drugs in the treatment of Helicobacter pylori infection
Aliment Pharmacol Ther 1997; 11 (Suppl. 1): 21 25. The role of antisecretory drugs in the treatment of Helicobacter pylori infection W. L. PETERSON Department of Internal Medicine, University of Texas
More informationRESEARCH ARTICLE. Abstract. Introduction
DOI:10.22034/APJCP.2017.18.4.927 Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole RESEARCH ARTICLE Outcomes of a Randomized Controlled Trial Comparing Modified High Dose
More informationGASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA
GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA MANAGEMENT Dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. For the majority
More informationComparison of Triple Therapy plus Probiotic Yogurt vs. Standard Triple Therapy on Helicobacter Pylori Eradication
Zahedan Journal of Research in Medical Sciences Journal homepage: www.zjrms.ir Comparison of Triple Therapy plus Probiotic Yogurt vs. Standard Triple Therapy on Helicobacter Pylori Eradication Vahid Mirzaee,*
More informationClinical Study Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
BioMed Research International Volume 2015, Article ID 163960, 6 pages http://dx.doi.org/10.1155/2015/163960 Clinical Study Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter
More informationAmerican College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
American Journal of Gastroenterology ISSN 0002-9270 C 2007 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2007.01393.x Published by Blackwell Publishing American College of Gastroenterology
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): November 22, 2011 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS
More informationIs the prescription of azithromycin instead of clarithromycin more effective in the sequential therapy of helicobacter pylori eradication?
ACADEMIE ROYALE DES SCIENCES D OUTRE-MER BULLETIN DES SEANCES Vol. 4 No. 3 June 215 pp. 177-182 ISSN: 1-4176 Is the prescription of azithromycin instead of clarithromycin more effective in the sequential
More informationEfficacy and Tolerability of a Third-Line, Levofloxacin-Based, 10-Day Sequential Therapy in Curing Resistant Helicobacter Pylori Infection
ORIGInAL PAPERs Efficacy and Tolerability of a Third-Line, Levofloxacin-Based, 10-Day Sequential Therapy in Curing Resistant Helicobacter Pylori Infection Antonio Tursi 1, Marcello Picchio 2, Walter Elisei
More informationEradication of H. pylori Infection in Patients Allergic to Penicillin Using Triple Therapy with a PPI, Metronidazole and Sitafloxacin
CASE REPORT Eradication of H. pylori Infection in Patients Allergic to Penicillin Using Triple Therapy with a PPI, Metronidazole and Sitafloxacin Takahisa Furuta 1, Mitsushige Sugimoto 2, Mihoko Yamade
More informationArab Journal of Gastroenterology
Arab Journal of Gastroenterology 14 (2013) 1 5 Contents lists available at SciVerse ScienceDirect Arab Journal of Gastroenterology journal homepage: www.elsevier.com/locate/ajg Original Article Penbactam
More informationI. Kalfus MD, D. Riff MD, R. Fathi PhD, D. Graham MD
A Randomized Double Blind Placebo Controlled Phase III Study to Assess the Safety and Efficacy of Rifabutin Triple Therapy (RHB-105) for Helicobacter pylori (H. pylori) Infection in Dyspepsia Patients
More informationRpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives
Esomeprazole 20mg Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8886Q) (029W) Gastric ulcer Peptic ulcer Treatment Phase: Initial treatment The therapy must be for initial treatment
More informationMaastricht Ⅴ /Florence
2016 21 10 577 Maastricht Ⅴ /Florence 200001 2015 10 8 9 Maastricht V 1 / 2 3 4 / 5 Maastricht Ⅴ Interpretation of Management of Helicobacter pylori Infection the Maastricht Ⅴ / Florence Consensus Report
More informationThe annual incidence of peptic ulcer disease in developed
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2003;1:273 278 Pretreatment Antimicrobial Susceptibility Testing Is Cost Saving in the Eradication of Helicobacter pylori MARCO ROMANO,* RICCARDO MARMO, ANTONIO
More informationSequioa Education Systems, Inc. 1
Functional Diagnostic Medicine Training Program Module 2 The Functional Diagnostic Medicine Approach in the Treatment of Gastrointestinal Dysfunction and Disease Dr. Wayne L. Sodano, D.C., D.A.B.C.I. &
More informationDrug Class Monograph
Drug Class Monograph Class: Proton Pump Inhibitors Drugs: Aciphex Sprinkle (rabeprazole), Dexilant (dexlansoprazole), Lansoprazole, Nexium (esomeprazole capsule, esomeprazole granules), Omeprazole, Pantoprazole,
More informationClinical significance of Helicobacter infection in children
Clinical significance of Helicobacter infection in children Marion Rowland and Brendan Drumm Department of Paediatrics, University College Dublin, Children's Research Centre, Our Lady's Hospital for Sick
More informationHybrid therapy as first-line regimen for Helicobacter pylori eradication in a high clarithromycin resistance area: a prospective open-label trial
ORIGINAL ARTICLE Annals of Gastroenterology (2018) 31, 1-6 Hybrid therapy as first-line regimen for Helicobacter pylori eradication in a high clarithromycin resistance area: a prospective open-label trial
More informationManagement of H. pylori Resistance
Management of H. pylori Resistance Manfred Kist, Erik Glocker, Nicole Wüppenhorst, Beate Hobmaier National Reference Centre for Helicobacter pylori Institute of Medical Microbiology and Hygiene Freiburg,
More informationRates of clarithromycin resistance in Helicobacter pylori sampled from healthy subjects in Cheonan, Korea
Rates of clarithromycin resistance in Helicobacter pylori sampled from healthy subjects in Cheonan, Korea Young Sam Yuk 1, Ga-Yeon Kim 2 1. Department of Biomedical Laboratory Science, Dankook University
More informationTreatment for H. pylori Infection. New Challenges With Antimicrobial Resistance
CLINICAL REVIEW Treatment for H. pylori Infection New Challenges With Antimicrobial Resistance Nimish Vakil, MD, FACP, FACG, AGAF, FASGE* and Dino Vaira, MDw Abstract: The treatment of Helicobacter pylori
More informationUpper Endoscopic Findings in Children with Recurrent Abdominal Pain: High Prevalence of Hiatus Hernia
Original Article Iran J Pediatr Sep 2012; Vol 22 (No 3), Pp: 309-313 Upper Endoscopic Findings in Children with Recurrent Abdominal Pain: High Prevalence of Hiatus Hernia Farzaneh Motamed 1,2, MD; Sayna
More informationFailure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates
cp60392 Module 1 Journal of Clinical Pathology 28/8/08 12:38:20 Topics: ; Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical
More informationOne-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers
Aliment Pharmacol Ther 1997; 11: 89 93. One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers J. LABENZ*, J.-P. IDSTRO M, B. TILLENBURG*,
More informationA PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS
A PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS Pages with reference to book, From 154 To 156 Javed Iqbal Kazi, Naeem Aon Jafarey, Syed Mahmood Alam ( Department
More informationGASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali
GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers
More informationORIGINAL INVESTIGATION. Maintenance Treatment Is Not Necessary After Helicobacter pylori Eradication and Healing of Bleeding Peptic Ulcer
ORIGINAL INVESTIGATION Maintenance Treatment Is Not Necessary After Helicobacter pylori Eradication and Healing of Bleeding Peptic Ulcer A 5-Year Prospective, Randomized, Controlled Study Chen-Chiung Liu,
More informationKEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.
INCIDENCE OF HELICOBACTER PYLORI WITH ACID PEPTIC DISEASE AND MALIGNANT CONDITIONS OF UPPER GASTROINTESTINAL TRACT IN A TERTIARY CENTRE - A PROSPECTIVE STUDY Karunamoorthy Rajachidambaram 1, Dinkaran Kaarthesan
More informationComparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in Detecting Helicobacter pylori Infection ABSTRACT
Original Article Rojborwonwitaya J, Vijitjunyakul N THAI J GASTROENTEROL 2005 Vol. 6 No. 2 May - Aug. 2005 55 Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in
More informationType of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection Hahn M, Fennerty M B, Corless C L, Magaret N, Lieberman D A, Faigel D O Record Status This is a critical
More informationTRANSPARENCY COMMITTEE OPINION. 13 December 2006
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 13 December 2006 HELIKIT 75 mg, powder for oral solution CIP : 343 132-1 Applicant : MAYOLY SPINDLER 13 Curea anhydrous
More informationRapid increase in the prevalence of metronidazole resistant Helicobacter pylori in the Netherlands.
Chapter 2 Rapid increase in the prevalence of metronidazole resistant Helicobacter pylori in the Netherlands. E.J.van der Wouden 1, A.A.van Zwet 2, J.C.Thijs 1, G.D.C.Vosmaer 3, J.A.J.Oom 4, A.de Jong
More informationTECHNOLOGY OVERVIEW: PHARMACEUTICALS
TECHNOLOGY OVERVIEW: PHARMACEUTICALS ISSUE 3.1 JUNE 1996 PHARMACEUTICAL MANAGEMENT OF PEPTIC ULCER DISEASE prepared by Ms. Christine Perras, BSc Phm Pharmaceutical Associate, CCOHTA and Dr. Nicolaas Otten,
More informationSURVEY IN IRAN OF CLARITHROMYCIN RESISTANCE IN HELICOBACTER PYLORI ISOLATES BY PCR-RFLP
SURVEY IN IRAN OF CLARITHROMYCIN RESISTANCE IN HELICOBACTER PYLORI ISOLATES BY PCR-RFLP Nourkhoda Sadeghifard 1, Teimour Seidnazari 1, Sobhan Ghafourian 1,3, Mohammad Soleimani 2, Abbas Maleki 1, Mostafa
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400
More informationHelicobacter pylori. Objectives. Upper Gastrointestinal Bleeding Peptic Ulcer Disease
Upper Gastrointestinal Bleeding Peptic Ulcer Disease Pharmacotherapy Issues in Acute Management and Secondary Prevention Peter J. Zed, B.Sc., B.Sc.(Pharm), Pharm.D. Pharmacotherapeutic Specialist - Emergency
More informationHelicobacter Connections. Barry Marshall
Helicobacter Connections Barry Marshall The greatest obstacle to knowledge is not ignorance, it is the illusion of knowledge. Daniel Boorstein - Historian Peptic Ulcers Duodenal Ulcer (DU) Gastric Ulcer
More informationUse of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori
Alimentary Pharmacology and Therapeutics Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori J. C. Delchier*,
More informationCorrelation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori
ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.
More informationHelicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師
Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師 Hp : Helicobacter pylori Part 1. Pathophysiology and immune response Pathogenesis of Hp infection Part 2. Clinical manifestation Part 3. Dx tests for
More informationHelicobacter pylori eradication an update on the latest therapies
Helicobacter pylori eradication an update on the latest therapies Author Yaxley, Julian, Chakravarty, Bhaskar Published 2014 Journal Title Australian Family Physician Copyright Statement 2014 Australian
More informationPeptic Ulcer Disease Update
Peptic Ulcer Disease Update Col Pat Storms RAM 2005 Disclosure Information 84th Annual AsMA Scientific Meeting Col Patrick Storms I have no financial relationships to disclose. I will discuss the following
More informationMANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia
More informationThe usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.
Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs
More informationÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ
ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ 205 206 ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ EPITHELIAL CELL TURNOVER IN NON-DYSPLASTIC GASTRIC MUCOSA ADJACENT TO EARLY AND
More informationISSN X (Print) Research Article
Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2015; 3(2B):631-637 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources)
More informationCommittee Approval Date: October 14, 2014 Next Review Date: October 2015
Medication Policy Manual Topic: esomeprazole-containing medications: - Nexium - Vimovo - esomeprazole strontium Policy No: dru039 Date of Origin: May 2001 Committee Approval Date: October 14, 2014 Next
More informationPharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network metaanalysis
Xin et al. BMC Gastroenterology (2016) 16:80 DOI 10.1186/s12876-016-0491-7 RESEARCH ARTICLE Open Access Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews
More informationProton Pump Inhibitors (PPIs) (Sherwood Employer Group)
Proton Pump Inhibitors (PPIs) (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf
More informationKeywords: Helicobacter pylori, Probiotic, Saccharomyces boulardii, Anti-helicobacter pylori eradication therapy.
Gastroenterology and Hepatology From Bed to Bench. 2013 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE The efficacy and safety of adding the probiotic Saccharomyces
More informationAssociation of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia
ADVANCES IN BIORESEARCH Adv. Biores., Vol 8 [3] May 2017: 137-141 2017 Society of Education, India Print ISSN 0976-4585; Online ISSN 2277-1573 Journal s URL:http://www.soeagra.com/abr.html CODEN: ABRDC3
More information